Ghaw A, Chunduri A, Chang A, Ortiz R, Kozlowska M, Kulkarni P
Brain Commun. 2024; 6(3):fcae194.
PMID: 38863575
PMC: 11166175.
DOI: 10.1093/braincomms/fcae194.
Kahnau P, Mieske P, Wilzopolski J, Kalliokoski O, Mandillo S, Holter S
BMC Biol. 2023; 21(1):256.
PMID: 37953247
PMC: 10642068.
DOI: 10.1186/s12915-023-01751-7.
Inserra A, Piot A, De Gregorio D, Gobbi G
CNS Drugs. 2023; 37(9):733-754.
PMID: 37603260
DOI: 10.1007/s40263-023-01008-5.
Syrova K, Sichova K, Danda H, Lhotkova E, Jorratt P, Pinterova-Leca N
Front Pharmacol. 2023; 14:1120419.
PMID: 36969854
PMC: 10033663.
DOI: 10.3389/fphar.2023.1120419.
Tirri M, Bilel S, Arfe R, Corli G, Marchetti B, Bernardi T
Front Psychiatry. 2022; 13:875722.
PMID: 35530025
PMC: 9069068.
DOI: 10.3389/fpsyt.2022.875722.
LSD degrades hippocampal spatial representations and suppresses hippocampal-visual cortical interactions.
Domenico C, Haggerty D, Mou X, Ji D
Cell Rep. 2021; 36(11):109714.
PMID: 34525364
PMC: 9798728.
DOI: 10.1016/j.celrep.2021.109714.
Use and abuse of dissociative and psychedelic drugs in adolescence.
Bates M, Trujillo K
Pharmacol Biochem Behav. 2021; 203:173129.
PMID: 33515586
PMC: 11578551.
DOI: 10.1016/j.pbb.2021.173129.
The HIV antiretroviral drug efavirenz has LSD-like properties.
Gatch M, Kozlenkov A, Huang R, Yang W, Nguyen J, Gonzalez-Maeso J
Neuropsychopharmacology. 2013; 38(12):2373-84.
PMID: 23702798
PMC: 3799056.
DOI: 10.1038/npp.2013.135.
Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.
Palenicek T, Fujakova M, Brunovsky M, Horacek J, Gorman I, Balikova M
Psychopharmacology (Berl). 2012; 225(1):75-93.
PMID: 22842791
DOI: 10.1007/s00213-012-2797-7.
Four factors underlying mouse behavior in an open field.
Tanaka S, Young J, Halberstadt A, Masten V, Geyer M
Behav Brain Res. 2012; 233(1):55-61.
PMID: 22569582
PMC: 3866095.
DOI: 10.1016/j.bbr.2012.04.045.
Modeling anxiety using adult zebrafish: a conceptual review.
Stewart A, Gaikwad S, Kyzar E, Green J, Roth A, Kalueff A
Neuropharmacology. 2011; 62(1):135-43.
PMID: 21843537
PMC: 3195883.
DOI: 10.1016/j.neuropharm.2011.07.037.
Cross-species assessments of motor and exploratory behavior related to bipolar disorder.
Henry B, Minassian A, Young J, Paulus M, Geyer M, Perry W
Neurosci Biobehav Rev. 2010; 34(8):1296-306.
PMID: 20398694
PMC: 2900445.
DOI: 10.1016/j.neubiorev.2010.04.002.
Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.
Halberstadt A, Buell M, Masten V, Risbrough V, Geyer M
Psychopharmacology (Berl). 2008; 201(1):55-66.
PMID: 18604652
PMC: 2929165.
DOI: 10.1007/s00213-008-1247-z.
A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor.
Young J, Minassian A, Paulus M, Geyer M, Perry W
Neurosci Biobehav Rev. 2007; 31(6):882-96.
PMID: 17706782
PMC: 2025688.
DOI: 10.1016/j.neubiorev.2007.05.009.
The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats.
Krebs-Thomson K, Ruiz E, Masten V, Buell M, Geyer M
Psychopharmacology (Berl). 2006; 189(3):319-29.
PMID: 17013638
DOI: 10.1007/s00213-006-0566-1.
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Marona-Lewicka D, Thisted R, Nichols D
Psychopharmacology (Berl). 2005; 180(3):427-35.
PMID: 15723230
DOI: 10.1007/s00213-005-2183-9.
Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats.
Krebs K, Geyer M
Psychopharmacology (Berl). 1994; 113(3-4):429-37.
PMID: 7862855
DOI: 10.1007/BF02245219.
The time and space machine: continuous measurement of drug-induced behavior patterns in the rat.
Stoff D, Stauderman K, Wyatt R
Psychopharmacology (Berl). 1983; 80(4):319-24.
PMID: 6414000
DOI: 10.1007/BF00432113.
Depletion of brain serotonin by 5,7-dihydroxytryptamine alters the response to amphetamine and the habituation of locomotor activity in rats.
Gately P, Poon S, Segal D, Geyer M
Psychopharmacology (Berl). 1985; 87(4):400-5.
PMID: 3936096
DOI: 10.1007/BF00432502.
Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens.
Mittman S, Geyer M
Psychopharmacology (Berl). 1989; 98(3):321-9.
PMID: 2501811
DOI: 10.1007/BF00451682.